Mifepristone Paternalism at the FDA

Journal of Law, Medicine and Ethics 51 (3):554-559 (2023)
  Copy   BIBTEX

Abstract

This article explores the role of the Food and Drug Administration (FDA) in drug approval and restrictions to mifepristone access in the context of historical regulation and current litigation.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2023.98

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,475

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S.Liam Bendicksen & Aaron S. Kesselheim - 2023 - Journal of Law, Medicine and Ethics 51 (2):448-449.
A Defence of Pharmaceutical Paternalism.David Teira - 2020 - Journal of Applied Philosophy 37 (4):528-542.
Hermeneutics of Food and Drug Regulatory Policy.Iii Joseph A. Tuminello - 2020 - Humana Mente 13 (38).
Cost‐effectiveness of an electronic medication ordering and administration system in reducing adverse drug events.Robert C. Wu, Audrey Laporte & Wendy J. Ungar - 2007 - Journal of Evaluation in Clinical Practice 13 (3):440-448.
Prescription Requirements and Patient Autonomy: Considering an Over‐the‐Counter Default.Madison Kilbride, Steven Joffe & Holly Fernandez Lynch - 2020 - Hastings Center Report 50 (6):15-26.
Risk assessment of genetically modified food and neoliberalism: An argument for democratizing the regulatory review protocol of the Food and Drug Administration.Zahra Meghani - 2014 - Journal of Agricultural and Environmental Ethics 27 (6):967–989.
A multi‐intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM‐Landskrona Integrated Medicines Management.Anna Bergkvist, Patrik Midlöv, Peter Höglund, Lisa Larsson & Tommy Eriksson - 2009 - Journal of Evaluation in Clinical Practice 15 (4):660-667.
Evaluation of medication errors via a computerized physician order entry system in an inpatient renal transplant unit.K. Marfo, D. Garcia, S. Khalique, K. Berger & A. Lu - 2011 - Transplant Research and Risk Management 2011.
Drug regulation in the philippines.Allan Grand A. Sobrepena - unknown
If Health Care Advertising Is a Problem, FDA-Style Regulation Is Not the Solution.Vanessa Carbonell - 2014 - American Journal of Bioethics 14 (3):46-47.
Accelerated drug approval: Meeting the ethical yardstick.Mattia Andreoletti & Alessandro Blasimme - 2023 - Bioethics 37 (7):647-655.
Three arguments against prescription requirements.Jessica Flanigan - 2012 - Journal of Medical Ethics 38 (10):579-586.
Reauthorization of PDUFA: An Exercise in Post-Market Drug Safety Reform.Peter Chang - 2008 - Journal of Law, Medicine and Ethics 36 (1):196-199.
iPLEDGE Allegiance to the Pill: Evaluation of Year 1 of a Birth Defect Prevention and Monitoring System.Toby L. Schonfeld, N. Jean Amoura & Christopher J. Kratochvil - 2009 - Journal of Law, Medicine and Ethics 37 (1):104-117.
Drug Trials, Doctors, and Developing Countries: Toward a Legal Definition of Informed Consent.Adina M. Newman - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):387.

Analytics

Added to PP
2023-12-14

Downloads
7 (#1,377,350)

6 months
7 (#419,843)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references